Articles

ASIPP Controlled Substance Guidelines:
Guidelines for the Use of Controlled Substances in theManagement of Chronic Pain

Sairam Atluri, MD, Mark V. Boswell, MD, PhD, Hans C. Hansen, MD, Andrea M. Trescot, MD, Vijay Singh, MD and Arthur E. Jordan, MD

NASPER:
Balancing Substance Abuse and Medical Necessity in Interventional Pain Management

Laxmaiah Manchikanti, MD, Keith R. Brown, PharmD, RPh and Vijay Singh, MD

Prevalence of Opioid Abuse in Interventional Pain Medicine Practice Settings:
A Randomized Clinical Evaluation

Laxmaiah Manchikanti, MD, Vidyasagar Pampati, MSc, Kim S. Damron, RN, Bert Fellows, MA, Renee C. Barnhill, RN, and Carla Beyer, RN

Prevalence of Illicit Drug use in Patients without Controlled Substance Abuse in Interventional Pain Management

Laxmaiah Manchikanti, MD, Vidyasagar Pampati, MSc, Kim S. Damron, RN, Carla D. Beyer, RN, BSN, and Renee C. Barnhill, RN, BSN

Prevalence of Prescription Drug Abuse and Dependency In Patients with Chronic Pain in Western Kentucky

Laxmaiah Manchikanti, MD, Vidyasagar Pampati, MSc, Kim S. Damron, RN, Carla D. Beyer, RN, BSN, Renee C. Barnhill, RN, BSN, and Bert Fellows, MA